These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38306846)
1. Canine glioblastoma-derived extracellular vesicles as precise carriers for glioblastoma imaging: Targeting across the blood-brain barrier. Villa A; De Mitri Z; Vincenti S; Crippa E; Castiglioni L; Gelosa P; Rebecchi M; Tosi D; Brunialti E; Oevermann A; Falleni M; Sironi L; Bello L; Mazzaferro V; Ciana P Biomed Pharmacother; 2024 Mar; 172():116201. PubMed ID: 38306846 [TBL] [Abstract][Full Text] [Related]
2. Methotrexate-Loaded Extracellular Vesicles Functionalized with Therapeutic and Targeted Peptides for the Treatment of Glioblastoma Multiforme. Ye Z; Zhang T; He W; Jin H; Liu C; Yang Z; Ren J ACS Appl Mater Interfaces; 2018 Apr; 10(15):12341-12350. PubMed ID: 29564886 [TBL] [Abstract][Full Text] [Related]
3. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients. García-Romero N; Carrión-Navarro J; Esteban-Rubio S; Lázaro-Ibáñez E; Peris-Celda M; Alonso MM; Guzmán-De-Villoria J; Fernández-Carballal C; de Mendivil AO; García-Duque S; Escobedo-Lucea C; Prat-Acín R; Belda-Iniesta C; Ayuso-Sacido A Oncotarget; 2017 Jan; 8(1):1416-1428. PubMed ID: 27902458 [TBL] [Abstract][Full Text] [Related]
4. Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents. Habimana-Griffin L; Ye D; Carpenter J; Prior J; Sudlow G; Marsala L; Mixdorf M; Rubin J; Chen H; Achilefu S J Biomed Opt; 2020 Feb; 25(2):1-13. PubMed ID: 32112540 [TBL] [Abstract][Full Text] [Related]
5. Focused Ultrasound-Mediated Blood-Brain Barrier Opening Increases Delivery and Efficacy of Etoposide for Glioblastoma Treatment. Wei HJ; Upadhyayula PS; Pouliopoulos AN; Englander ZK; Zhang X; Jan CI; Guo J; Mela A; Zhang Z; Wang TJC; Bruce JN; Canoll PD; Feldstein NA; Zacharoulis S; Konofagou EE; Wu CC Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):539-550. PubMed ID: 33346092 [TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools. Cela I; Capone E; Trevisi G; Sala G Semin Cancer Biol; 2024 Jun; 101():25-43. PubMed ID: 38754752 [TBL] [Abstract][Full Text] [Related]
7. Emerging extracellular vesicle-based carriers for glioblastoma diagnosis and therapy. Wang J; Liu Y; Liu F; Gan S; Roy S; Hasan I; Zhang B; Guo B Nanoscale; 2023 Jul; 15(26):10904-10938. PubMed ID: 37337814 [TBL] [Abstract][Full Text] [Related]
8. Targeted blood-brain barrier penetration and precise imaging of infiltrative glioblastoma margins using hybrid cell membrane-coated ICG liposomes. Liu P; Lan S; Gao D; Hu D; Chen Z; Li Z; Jiang G; Sheng Z J Nanobiotechnology; 2024 Oct; 22(1):603. PubMed ID: 39367395 [TBL] [Abstract][Full Text] [Related]
9. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151 [TBL] [Abstract][Full Text] [Related]
11. A Microfluidics-Based Scalable Approach to Generate Extracellular Vesicles with Enhanced Therapeutic MicroRNA Loading for Intranasal Delivery to Mouse Glioblastomas. Wang K; Kumar US; Sadeghipour N; Massoud TF; Paulmurugan R ACS Nano; 2021 Nov; 15(11):18327-18346. PubMed ID: 34723509 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain Barrier. Kim M; Ma DJ; Calligaris D; Zhang S; Feathers RW; Vaubel RA; Meaux I; Mladek AC; Parrish KE; Jin F; Barriere C; Debussche L; Watters J; Tian S; Decker PA; Eckel-Passow JE; Kitange GJ; Johnson AJ; Parney IF; Anastasiadis PZ; Agar NYR; Elmquist WF; Sarkaria JN Mol Cancer Ther; 2018 Sep; 17(9):1893-1901. PubMed ID: 29970480 [TBL] [Abstract][Full Text] [Related]
13. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma. Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models. Qiu L; Cai Y; Geng Y; Yao X; Wang L; Cao H; Zhang X; Wu Q; Kong D; Ding D; Shi Y; Wang Y; Wu J Acta Biomater; 2022 Dec; 154():424-442. PubMed ID: 36367475 [TBL] [Abstract][Full Text] [Related]
15. Proteome profiling of salivary small extracellular vesicles in glioblastoma patients. Müller Bark J; Trevisan França de Lima L; Zhang X; Broszczak D; Leo PJ; Jeffree RL; Chua B; Day BW; Punyadeera C Cancer; 2023 Sep; 129(18):2836-2847. PubMed ID: 37254878 [TBL] [Abstract][Full Text] [Related]